2021-2027 China Asthma Medication Market Analysis and Trends Report

1 Introduction to Research & Analysis Reports

　1.1 Asthma Medication Market Definition

　1.2 Market Segments

　　1.2.1 Segment by Type

　　1.2.2 Segment by Application

　1.3 China Asthma Medication Market Overview

　1.4 Methodology & Sources of Information

　　1.4.1 Research Methodology

　　1.4.2 Research Process

　　1.4.3 Base Year

2 China Asthma Medication Overall Market Size

　2.1 China Asthma Medication Market Size: 2021 VS 2027

　2.2 China Asthma Medication Revenue, Prospects & Forecasts: 2016-2027

　2.3 China Asthma Medication Sales: 2016-2027

3 Company Landscape

　3.1 Top Asthma Medication Players in China Market

　3.2 Top China Asthma Medication Companies Ranked by Revenue

　3.3 China Asthma Medication Revenue by Companies

　3.4 China Asthma Medication Sales by Companies

　3.5 China Asthma Medication Price by Manufacturer (2016-2021)

　3.6 Top 3 and Top 5 Asthma Medication Companies in China Market, by Revenue in 2020

　3.7 Manufacturers Asthma Medication Product Type

　3.8 Tier 1, Tier 2 and Tier 3 Asthma Medication Players in China Market

　　3.8.1 List of Tier 1 Asthma Medication Companies in China

　　3.8.2 List of Tier 2 and Tier 3 Asthma Medication Companies in China

4 Sights by Type

　4.1 Overview

　　4.1.1 By Type - China Asthma Medication Market Size Markets, 2021 & 2027

轉-載-自：http://www.5269660.cn/9/18/2021-2027-China-Asthma-Medication-Market-Analysis-and-Trends-Report.html

　　4.1.2 Quick-Relief Medications

　　4.1.3 Long-Term Control Medications

　　4.1.4 Asthma Medications During Pregnancy

　4.2 By Type - China Asthma Medication Revenue & Forecasts

　　4.2.1 By Type - China Asthma Medication Revenue, 2016-2021

　　4.2.2 By Type - China Asthma Medication Revenue, 2022-2027

　　4.2.3 By Type - China Asthma Medication Revenue Market Share, 2016-2027

　4.3 By Type - China Asthma Medication Sales & Forecasts

　　4.3.1 By Type - China Asthma Medication Sales, 2016-2021

　　4.3.2 By Type - China Asthma Medication Sales, 2022-2027

　　4.3.3 By Type - China Asthma Medication Sales Market Share, 2016-2027

　4.4 By Type - China Asthma Medication Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

　5.1 Overview

　　5.1.1 By Application - China Asthma Medication Market Size, 2021 & 2027

　　5.1.2 Children

　　5.1.3 Adolescent

　　5.1.4 Adult

　5.2 By Application - China Asthma Medication Revenue & Forecasts

　　5.2.1 By Application - China Asthma Medication Revenue, 2016-2021

　　5.2.2 By Application - China Asthma Medication Revenue, 2022-2027

　　5.2.3 By Application - China Asthma Medication Revenue Market Share, 2016-2027

　5.3 By Application - China Asthma Medication Sales & Forecasts

　　5.3.1 By Application - China Asthma Medication Sales, 2016-2021

　　5.3.2 By Application - China Asthma Medication Sales, 2022-2027

　　5.3.3 By Application - China Asthma Medication Sales Market Share, 2016-2027

　5.4 By Application - China Asthma Medication Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

　6.1 Dulera

　　6.1.1 Dulera Corporation Information

　　6.1.2 Dulera Overview

　　6.1.3 Dulera Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.1.4 Dulera Asthma Medication Product Description

　　6.1.5 Dulera Recent Developments

　6.2 QVAR

　　6.2.1 QVAR Corporation Information

　　6.2.2 QVAR Overview

　　6.2.3 QVAR Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.2.4 QVAR Asthma Medication Product Description

　　6.2.5 QVAR Recent Developments

　6.3 Glaxosmithkline plc

　　6.3.1 Glaxosmithkline plc Corporation Information

　　6.3.2 Glaxosmithkline plc Overview

　　6.3.3 Glaxosmithkline plc Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.3.4 Glaxosmithkline plc Asthma Medication Product Description

　　6.3.5 Glaxosmithkline plc Recent Developments

　6.4 MAP Pharmaceuticals,Inc

　　6.4.1 MAP Pharmaceuticals,Inc Corporation Information

　　6.4.2 MAP Pharmaceuticals,Inc Overview

　　6.4.3 MAP Pharmaceuticals,Inc Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.4.4 MAP Pharmaceuticals,Inc Asthma Medication Product Description

　　6.4.5 MAP Pharmaceuticals,Inc Recent Developments

　6.5 Merck & Co. Inc

　　6.5.1 Merck & Co. Inc Corporation Information

　　6.5.2 Merck & Co. Inc Overview

　　6.5.3 Merck & Co. Inc Asthma Medication Sales and Revenue in China Market (2016-2021)

2021-2027中國哮喘藥物市場分析和趨勢報告

　　6.5.4 Merck & Co. Inc Asthma Medication Product Description

　　6.5.5 Merck & Co. Inc Recent Developments

　6.6 AstraZeneca plc

　　6.6.1 AstraZeneca plc Corporation Information

　　6.6.2 AstraZeneca plc Overview

　　6.6.3 AstraZeneca plc Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.6.4 AstraZeneca plc Asthma Medication Product Description

　　6.6.5 AstraZeneca plc Recent Developments

　6.7 Roche Holdings Ltd

　　6.7.1 Roche Holdings Ltd Corporation Information

　　6.7.2 Roche Holdings Ltd Overview

　　6.7.3 Roche Holdings Ltd Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.7.4 Roche Holdings Ltd Asthma Medication Product Description

　　6.7.5 Roche Holdings Ltd Recent Developments

　6.8 Genentech Inc

　　6.8.1 Genentech Inc Corporation Information

　　6.8.2 Genentech Inc Overview

　　6.8.3 Genentech Inc Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.8.4 Genentech Inc Asthma Medication Product Description

　　6.8.5 Genentech Inc Recent Developments

　6.9 Sepracor, Inc

　　6.9.1 Sepracor, Inc Corporation Information

　　6.9.2 Sepracor, Inc Overview

　　6.9.3 Sepracor, Inc Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.9.4 Sepracor, Inc Asthma Medication Product Description

　　6.9.5 Sepracor, Inc Recent Developments

　6.10 Schering-Plough Corp

　　6.10.1 Schering-Plough Corp Corporation Information

　　6.10.2 Schering-Plough Corp Overview

　　6.10.3 Schering-Plough Corp Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.10.4 Schering-Plough Corp Asthma Medication Product Description

　　6.10.5 Schering-Plough Corp Recent Developments

　6.11 Sanofi-Aventis

　　6.11.1 Sanofi-Aventis Corporation Information

　　6.11.2 Sanofi-Aventis Overview

　　6.11.3 Sanofi-Aventis Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.11.4 Sanofi-Aventis Asthma Medication Product Description

　　6.11.5 Sanofi-Aventis Recent Developments

　6.12 Theravance Inc

　　6.12.1 Theravance Inc Corporation Information

　　6.12.2 Theravance Inc Overview

　　6.12.3 Theravance Inc Asthma Medication Sales and Revenue in China Market (2016-2021)

　　6.12.4 Theravance Inc Asthma Medication Product Description

　　6.12.5 Theravance Inc Recent Developments

7 China Asthma Medication Production Capacity, Analysis

　7.1 China Asthma Medication Production Capacity, 2016-2027

　7.2 Asthma Medication Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

　8.1 Market Opportunities & Trends

　8.2 Market Drivers

　8.3 Market Restraints

9 Asthma Medication Supply Chain Analysis

　9.1 Asthma Medication Industry Value Chain

2021-2027中國哮喘藥物市場分析和趨勢報告

　9.2 Asthma Medication Upstream Market

　9.3 Asthma Medication Downstream and Clients

　9.4 Marketing Channels Analysis

　　9.4.1 Marketing Channels

　　9.4.2 Asthma Medication Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

　11.1 Note

　11.2 Examples of Clients

　11.3 Author Details

　11.4 Disclaimer

List of Tables

　Table 1. Key Players of Asthma Medication in China Market

　Table 2. Top Asthma Medication Players in China Market, Ranking by Revenue (2019)

　Table 3. China Asthma Medication Revenue by Companies, (US$, Mn), 2016-2021

　Table 4. China Asthma Medication Revenue Share by Companies, 2016-2021

　Table 5. China Asthma Medication Sales by Companies, (K Units), 2016-2021

　Table 6. China Asthma Medication Sales Share by Companies, 2016-2021

　Table 7. Key Manufacturers Asthma Medication Price (2016-2021) & (USD/Unit)

　Table 8. Manufacturers Asthma Medication Product Type

　Table 9. List of Tier 1 Asthma Medication Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 10. List of Tier 2 and Tier 3 Asthma Medication Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 11. Major Manufacturers of Quick-Relief Medications

　Table 12. Major Manufacturers of Long-Term Control Medications

　Table 13. By Type – China Asthma Medication Revenue, (US$, Mn), 2021 & 2027

　Table 14. By Type - China Asthma Medication Revenue (US$, Mn), 2016-2021

　Table 15. By Type - China Asthma Medication Revenue (US$, Mn), 2022-2027

　Table 16. By Type - China Asthma Medication Sales (K Units), 2016-2021

　Table 17. By Type - China Asthma Medication Sales (K Units), 2022-2027

　Table 18. By Application – China Asthma Medication Revenue, (US$, Mn), 2021 VS 2027

　Table 19. By Application - China Asthma Medication Revenue (US$, Mn), 2016-2021

　Table 20. By Application - China Asthma Medication Revenue (US$, Mn), 2022-2027

　Table 21. By Application - China Asthma Medication Sales (K Units), 2016-2021

　Table 22. By Application - China Asthma Medication Sales (K Units), 2022-2027

　Table 23. Dulera Corporation Information

　Table 24. Dulera Description and Major Businesses

　Table 25. Dulera Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 26. Dulera Asthma Medication Product

　Table 27. Dulera Recent Developments

　Table 28. QVAR Corporation Information

　Table 29. QVAR Description and Major Businesses

　Table 30. QVAR Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 31. QVAR Asthma Medication Product

　Table 32. QVAR Recent Developments

　Table 33. Glaxosmithkline plc Corporation Information

　Table 34. Glaxosmithkline plc Description and Major Businesses

　Table 35. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 36. Glaxosmithkline plc Asthma Medication Product

　Table 37. Glaxosmithkline plc Recent Developments

　Table 38. MAP Pharmaceuticals,Inc Corporation Information

　Table 39. MAP Pharmaceuticals,Inc Description and Major Businesses

　Table 40. MAP Pharmaceuticals,Inc Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 41. MAP Pharmaceuticals,Inc Asthma Medication Product

　Table 42. MAP Pharmaceuticals,Inc Recent Developments

　Table 43. Merck & Co. Inc Corporation Information

2021-2027 zhōngguó xiāochuǎn yàowù shìchǎng fēnxī hé qūshì bàogào

　Table 44. Merck & Co. Inc Description and Major Businesses

　Table 45. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 46. Merck & Co. Inc Asthma Medication Product

　Table 47. Merck & Co. Inc Recent Developments

　Table 48. AstraZeneca plc Corporation Information

　Table 49. AstraZeneca plc Description and Major Businesses

　Table 50. AstraZeneca plc Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 51. AstraZeneca plc Asthma Medication Product

　Table 52. AstraZeneca plc Recent Developments

　Table 53. Roche Holdings Ltd Corporation Information

　Table 54. Roche Holdings Ltd Description and Major Businesses

　Table 55. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 56. Roche Holdings Ltd Asthma Medication Product

　Table 57. Roche Holdings Ltd Recent Developments

　Table 58. Genentech Inc Corporation Information

　Table 59. Genentech Inc Description and Major Businesses

　Table 60. Genentech Inc Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 61. Genentech Inc Asthma Medication Product

　Table 62. Genentech Inc Recent Developments

　Table 63. Sepracor, Inc Corporation Information

　Table 64. Sepracor, Inc Description and Major Businesses

　Table 65. Sepracor, Inc Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 66. Sepracor, Inc Asthma Medication Product

　Table 67. Sepracor, Inc Recent Developments

　Table 68. Schering-Plough Corp Corporation Information

　Table 69. Schering-Plough Corp Description and Major Businesses

　Table 70. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 71. Schering-Plough Corp Asthma Medication Product

　Table 72. Schering-Plough Corp Recent Developments

　Table 73. Sanofi-Aventis Corporation Information

　Table 74. Sanofi-Aventis Description and Major Businesses

　Table 75. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 76. Sanofi-Aventis Asthma Medication Product

　Table 77. Sanofi-Aventis Recent Developments

　Table 78. Theravance Inc Corporation Information

　Table 79. Theravance Inc Description and Major Businesses

　Table 80. Theravance Inc Asthma Medication Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

　Table 81. Theravance Inc Asthma Medication Product

　Table 82. Theravance Inc Recent Developments

　Table 83. Asthma Medication Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)

　Table 84. China Asthma Medication Capacity Market Share of Key Manufacturers, 2019-2021

　Table 85. Asthma Medication Market Opportunities & Trends in China Market

　Table 86. Asthma Medication Market Drivers in China Market

　Table 87. Asthma Medication Market Restraints in China Market

　Table 88. Asthma Medication Raw Materials

　Table 89. Asthma Medication Raw Materials Suppliers in China Market

　Table 90. Typical Asthma Medication Downstream

　Table 91. Asthma Medication Downstream Clients in China Market

　Table 92. Asthma Medication Distributors and Sales Agents in China Market

List of Figures

　Figure 1. Asthma Medication Product Picture

　Figure 2. Asthma Medication Segment by Type

　Figure 3. Asthma Medication Segment by Application

　Figure 4. China Asthma Medication Market Overview: 2020

　Figure 5. China Asthma Medication Market Size: 2021 VS 2027 (US$, Mn)

2021-2027中國喘息薬の市場分析とトレンドの報告書

　Figure 6. China Asthma Medication Revenue, 2016-2027 (US$, Mn)

　Figure 7. Asthma Medication Sales in China Market: 2016-2027 (K Units)

　Figure 8. The Top 3 and 5 Players Market Share by Asthma Medication Revenue in 2020

　Figure 9. Quick-Relief Medications Product Picture

　Figure 10. Long-Term Control Medications Product Picture

　Figure 11. Asthma Medications During Pregnancy Product Picture

　Figure 12. By Type - China Asthma Medication Sales Market Share, 2016-2027

　Figure 13. By Type - China Asthma Medication Revenue Market Share, 2016-2027

　Figure 14. By Type - China Asthma Medication Price (USD/Unit), 2016-2027

　Figure 15. Children

　Figure 16. Adolescent

　Figure 17. Adult

　Figure 18. By Application - China Asthma Medication Sales Market Share, 2016-2027

　Figure 19. By Application - China Asthma Medication Revenue Market Share, 2016-2027

　Figure 20. By Application - China Asthma Medication Price (USD/Unit), 2016-2027

　Figure 21. Dulera Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 22. QVAR Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 23. Glaxosmithkline plc Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 24. MAP Pharmaceuticals,Inc Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 25. Merck & Co. Inc Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 26. AstraZeneca plc Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 27. Roche Holdings Ltd Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 28. Genentech Inc Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 29. Sepracor, Inc Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 30. Schering-Plough Corp Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 31. Sanofi-Aventis Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 32. Theravance Inc Asthma Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 33. China Asthma Medication Production Capacity (K Units), 2016-2027

　Figure 34. Asthma Medication Industry Value Chain

　Figure 35. Marketing Channels

　　http://www.5269660.cn/9/18/2021-2027-China-Asthma-Medication-Market-Analysis-and-Trends-Report.html

　　……